SearchDictionaryMobileLogin

Crucial roles of binding sites for NF-kappaB and C/EBPs in IkappaB-zeta-mediated transcriptional activation.

AbstractIkappaB-zeta [inhibitor of NF-kappaB (nuclear factor kappaB) zeta] is a nuclear protein that is induced upon stimulation of TLRs (Toll-like receptors) and IL (interleukin)-1 receptor. IkappaB-zeta harbours C-terminal ankyrin repeats that interact with NF-kappaB. Our recent studies have shown that, upon stimulation, IkappaB-zeta is essential for the induction of a subset of inflammatory genes, represented by IL-6, whereas it inhibits the expression of TNF (tumour necrosis factor)-alpha. In the present study, we investigated mechanisms that determine the different functions of IkappaB-zeta. We found that co-expression of IkappaB-zeta and the NF-kappaB subunits synergistically activates transcription of the hBD-2 (human beta-defensin 2) and NGAL (neutrophil gelatinase-associated lipocalin) genes, whereas it inhibits transcription of E-selectin. Reporter analyses indicated that, in addition to an NF-kappaB-binding site, a flanking C/EBP (CCAAT/enhancer-binding protein)-binding site in the promoters is essential for the IkappaB-zeta-mediated transcriptional activation. Using an artificial promoter consisting of the NF-kappaB- and C/EBP-binding sites, transcriptional activation was observed upon co-transfection with IkappaB-zeta and NF-kappaB, indicating that these sequences are minimal elements that confer the IkappaB-zeta-mediated transcriptional activation. Chromatin immunoprecipitation assays and knockdown experiments showed that both IkappaB-zeta and the NF-kappaB subunits were recruited to the NGAL promoter and were essential for the transcriptional activation of the hBD-2 and NGAL promoters on stimulation with IL-1beta. The activation of the NGAL promoter by transfection of IkappaB-zeta and NF-kappaB was suppressed in C/EBPbeta-depleted cells. Thus IkappaB-zeta acts as an essential transcriptional activator by forming a complex with NF-kappaB on promoters harbouring the NF-kappaB- and C/EBP-binding sites, upon stimulation of TLRs or IL-1 receptor.
AuthorsSusumu Matsuo, Soh Yamazaki, Koichiro Takeshige, Tatsushi Muta (Affiliation: Department of Molecular and Cellular Biochemistry, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.)
JournalThe Biochemical journal (Biochem J) Vol. 405 Issue 3 Pg. 605-15 (Aug 1 2007) ISSN: 1470-8728 England
PMID17447895 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Acute-Phase Proteins
  • CCAAT-Enhancer-Binding Proteins
  • LCN2 protein, human
  • Lipocalins
  • NF-kappa B
  • NFKBIZ protein, human
  • Nuclear Proteins
  • Proto-Oncogene Proteins
  • RNA, Messenger
Topics
  • Acute-Phase Proteins (metabolism)
  • Binding Sites
  • CCAAT-Enhancer-Binding Proteins (metabolism)
  • Cell Line
  • Humans
  • Lipocalins
  • NF-kappa B (metabolism)
  • Nuclear Proteins (metabolism)
  • Promoter Regions, Genetic
  • Protein Binding
  • Proto-Oncogene Proteins (metabolism)
  • RNA Interference
  • RNA, Messenger (metabolism)
  • Transcription, Genetic
  • Transcriptional Activation